Grant opportunities

Discuss a grant opportunity

If you know of a funding announcement where a quantitative point-of-care immunoassay platform could contribute, or you are leading a proposal that needs an industry partner, tell us here.

See programs already in scope

What helps us respond quickly

  • The program name, funder and opportunity number, with a link if there is one
  • The deadline and expected award size and period
  • Who would lead the application
  • The role you see for OncoFirm: applicant, co-applicant, subrecipient, technology provider or consultant
  • What you or your institution would contribute

Not sure which program fits? Read how the research program is funded or send a general collaboration inquiry instead.

Grant opportunity form

Please do not include confidential or patient-identifiable information. Submitting this form does not create a confidential, contractual, advisory, funding or partnership relationship. Our privacy policy explains how we handle the details you send.

    Discuss a Grant Opportunity


    OncoFirm™ Diagnostics welcomes information regarding federal, state, foundation,
    philanthropic, academic, and private funding opportunities that may support
    cancer diagnostic research, biomarker development, fluorescent lateral flow
    technology, digital diagnostics, artificial intelligence, clinical research,
    and commercialization.


    Please provide as much information as possible so our team can evaluate the
    opportunity.

    1. Your Contact Information

    2. Organization Type

    3. Funding Opportunity Information

    4. Research Area

    5. Opportunity Stage

    6. Proposed Relationship With OncoFirm

    7. Scientific / Technical Opportunity

    8. Collaboration Requirements

    9. Supporting Documents


    You may upload a funding announcement, solicitation, program description,
    research concept, or other non-confidential supporting document.


    Please do not submit confidential proprietary information,
    patient-identifiable information, protected health information (PHI),
    or sensitive clinical records through this form.

    10. Follow-Up


    Questions about grant opportunities

    Yes. Program staff can also reach us directly at [email protected].

    Tell us anyway. If the timing does not work for this round we can plan for the next receipt date.

    Yes, where the consultant has relevant experience with diagnostics or small business programs.

    Useful before you submit

    Research and regulatory status

    OncoFirm™ technologies described on this site are in research and development. Their performance characteristics have not been established, and no OncoFirm product has been cleared, approved or authorized by the U.S. Food and Drug Administration. Nothing here is medical advice. Reference to a federal agency or funding program does not imply endorsement, funding, sponsorship or affiliation.